Almac speeds up niche product launches in Europe

Almac has added another Late Stage Customisation Suite to its commercial facilities, which will assist in the launch of orphan drug and niche products in Europe.

Almac has added another Late Stage Customisation Suite to its commercial facilities at Craigavon, Ireland, which the contract research organisation says will assist in the launch of orphan drug and niche products in Europe.

The firm says there is a growing requirement to support clients with their EU product launches, reduce stock holdings and provide greater flexibility with regional packs.

‘Late stage customisation involves working with the client and understanding their country launch requirements to develop an EU regional supply strategy,’ said Mark English, distribution manager at Almac.

‘Grouping countries by language, allowing for multi-language packs to service multiple markets, with country specific information added at point of despatch, provides significant cost advantages.’

Historically the countries were grouped together based on geographical proximity to ensure that distribution to the end user was as short as possible. However wi